Income Statement QingSong Health Corporation

Equities

2661

KYG7314Y1044

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E. Other stock markets 08:08:15 11/03/2026 GMT			5-day change	1st Jan Change
109.90 ^HKD	+8.38%		+15.32%	+60.32%

01-19	QingSong Health's IPO Stabilization Period Ends	MT
12-23	Hong Kong Stocks Ease Ahead of Christmas Break; New Listings See Mixed Debuts	MT

3b5f.Q5piET2oRrY5Vb4Ozxf290o8VKcewEmGLjaynY7W_wQ.GdsgRQvGd9NsN858uHa_2glqLeVmjD73HH7_rvSRrX4nwj1_dMop2nI-7w

Published financial data: QINGSONG HEALTH CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2022	2023	2024
Revenues	394M	490M	945M
Total Revenues	394M	490M	945M
Cost of Goods Sold, Total	68.44M	98.49M	583M
Gross Profit	325M	391M	362M
Selling General & Admin Expenses, Total	126M	187M	227M
Provision for Bad Debts	200K	291K	44K
R&D Expenses	52.82M	61.39M	72.04M
Other Operating Expenses	-	-	3.03M
Other Operating Expenses, Total	179M	249M	302M
Operating Income	147M	143M	59.48M
Interest And Investment Income	8.44M	9.07M	10.87M
Net Interest Expenses	8.44M	9.07M	10.87M
Currency Exchange Gains (Loss)	-10.01M	-2.39M	-1.83M
Other Non Operating Income (Expenses)	7M	2K	-11.16M
EBT, Excl. Unusual Items	152M	149M	57.36M
Gain (Loss) On Sale Of Investments	5M	3.5M	116K
Gain (Loss) On Sale Of Assets	-	-51K	282K
Other Unusual Items	-151M	-48.3M	-50.37M
EBT, Incl. Unusual Items	6.34M	105M	7.38M
Income Tax Expense	15.44M	7.37M	-1.61M
Earnings From Continuing Operations	-9.1M	97.17M	8.99M
Earnings Of Discontinued Operations	7.04M	-23.52M	1.41M
Net Income to Company	-2.06M	73.64M	10.4M
Net Income - (IS)	-2.06M	73.64M	10.4M
Net Income to Common Incl Extra Items	-2.06M	73.64M	10.4M
Net Income to Common Excl. Extra Items	-9.1M	97.17M	8.99M
Per Share Items
Net EPS - Basic	-0.03	0.92	0.13
Basic EPS - Continuing Operations	-0.11	1.21	0.11
Basic Weighted Average Shares Outstanding	80.07M	80.07M	80.07M
Net EPS - Diluted	-0.03	0.6	0.11
Diluted EPS - Continuing Operations	-0.11	0.72	0.1
Diluted Weighted Average Shares Outstanding	80.07M	202M	101M
Normalized Basic EPS	1.19	1.17	0.45
Normalized Diluted EPS	1.19	0.46	0.36
Supplemental Items
EBITDA	147M	143M	59.7M
EBITA	147M	143M	59.48M
EBIT	147M	143M	59.48M
Effective Tax Rate - (Ratio)	243.52	7.05	-21.82
Current Domestic Taxes	5.46M	1.01M	1.44M
Total Current Taxes	5.46M	1.01M	1.44M
Total Deferred Taxes	9.98M	6.36M	-3.06M
Normalized Net Income	94.98M	93.36M	35.85M
Interest on Long-Term Debt	123K	318K	337K
Supplemental Operating Expense Items
Advertising Expense	48.15M	107M	129M
Selling and Marketing Expenses	65.8M	124M	159M
General and Administrative Expenses	59.81M	63.27M	68.53M
Research And Development Expense From Footnotes	52.82M	61.39M	72.04M
Stock-Based Comp., R&D Exp. (Total)	608K	362K	4.1M
Stock-Based Comp., S&M Exp. (Total)	775K	333K	3.2M
Stock-Based Comp., G&A Exp. (Total)	6.29M	474K	5.65M
Total Stock-Based Compensation	7.67M	1.17M	12.95M

Fiscal Period: December	2022	2023	2024
Assets
Cash And Equivalents	296M	293M	363M
Short Term Investments	-	28.42M	-
Total Cash And Short Term Investments	296M	322M	363M
Accounts Receivable, Total	105M	172M	144M
Other Receivables	9.93M	13.3M	13.2M
Total Receivables	115M	185M	157M
Restricted Cash	71.82M	91.75M	55.4M
Other Current Assets, Total	103M	2.15M	6.64M
Total Current Assets	586M	601M	582M
Gross Property Plant And Equipment	10.79M	7.86M	3.67M
Accumulated Depreciation	-1.72M	-2M	-1.79M
Net Property Plant And Equipment	9.07M	5.86M	1.88M
Long-term Investments	-	81.89M	84.41M
Other Intangibles, Total	17.7M	17.65M	19.87M
Deferred Tax Assets Long-Term	-	-	1.34M
Total Assets	612M	706M	689M
Liabilities
Accounts Payable, Total	21.54M	57.08M	48.79M
Accrued Expenses, Total	101M	113M	81.31M
Short-term Borrowings	1.6B	1.68B	1.75B
Current Portion of Leases	4.03M	4.41M	35K
Current Income Taxes Payable	463K	1.21M	3.12M
Unearned Revenue Current, Total	64.98M	22.76M	7.03M
Other Current Liabilities	51.48M	11.13M	4.77M
Total Current Liabilities	1.84B	1.89B	1.9B
Long-Term Leases	3.86M	92K	18K
Deferred Tax Liability Non Current	4.47M	10.82M	9.12M
Total Liabilities	1.85B	1.9B	1.91B
Common Stock, Total	49K	49K	49K
Retained Earnings	-1.19B	-1.11B	-1.13B
Comprehensive Income and Other	-55.48M	-86.28M	-91.09M
Total Common Equity	-1.24B	-1.2B	-1.22B
Minority Interest	154K	125K	-
Total Equity	-1.24B	-1.2B	-1.22B
Total Liabilities And Equity	612M	706M	689M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	80.07M	80.07M	80.07M
ECS Total Common Shares Outstanding	80.07M	80.07M	80.07M
Book Value / Share	-15.5	-14.96	-15.22
Tangible Book Value	-1.26B	-1.22B	-1.24B
Tangible Book Value Per Share	-15.72	-15.18	-15.47
Total Debt	1.61B	1.69B	1.75B
Net Debt	1.31B	1.37B	1.39B
Minority Interest, Total (Incl. Fin. Div)	154K	125K	-
Account Code - Inventory Valuation	3	-	-
Full Time Employees	-	-	195
Accumulated Allowance for Doubtful Accounts (Supple)	120K	365K	400K

Fiscal Period: December	2022	2023	2024
Net Income	-2.06M	73.64M	10.4M
Depreciation & Amortization - CF	5.74M	4.62M	4.93M
Depreciation & Amortization, Total	5.74M	4.62M	4.93M
Amortization of Deferred Charges, Total - (CF)	29K	46K	46K
(Gain) Loss From Sale Of Asset	117K	1K	16K
(Gain) Loss on Sale of Investments - (CF)	146M	44.8M	50.26M
Stock-Based Compensation (CF)	7.67M	1.17M	12.95M
Provision and Write-off of Bad Debts	200K	291K	44K
Net Cash From Discontinued Operations	-	51K	-282K
Other Operating Activities, Total	20.81M	7.8M	-1.71M
Change In Accounts Receivable	-28.32M	-67.62M	27.09M
Change In Accounts Payable	-36.2M	35.53M	-8.29M
Change in Unearned Revenues	-83.09M	-42.22M	-15.73M
Change in Other Net Operating Assets	26.67M	-50.28M	4.07M
Cash from Operations	57.2M	7.83M	83.79M
Capital Expenditure	-	-181K	-1M
Sale of Property, Plant, and Equipment	137K	-	-
Cash Acquisitions	-	-	-2.22M
Investment in Marketable and Equity Securities, Total	-	-108M	28.57M
Other Investing Activities, Total	-95.03M	103M	-8.81M
Cash from Investing	-94.9M	-4.89M	16.53M
Short Term Debt Repaid, Total	-	-	-26.08M
Long-Term Debt Repaid, Total	-4.99M	-4.95M	-4.54M
Total Debt Repaid	-4.99M	-4.95M	-30.62M
Cash from Financing	-4.99M	-4.95M	-30.62M
Foreign Exchange Rate Adjustments	639K	-385K	-343K
Net Change in Cash	-42.04M	-2.39M	69.36M
Supplemental Items
Cash Income Tax Paid (Refund)	7.34M	261K	-
Levered Free Cash Flow	-	71.32M	53.8M
Unlevered Free Cash Flow	-	71.32M	53.8M
Change In Net Working Capital	-	23.52M	289K
Net Debt Issued / Repaid	-4.99M	-4.95M	-30.62M

Fiscal Period: December	2022	2023	2024
Profitability
Return on Assets	-	13.53	5.33
Return on Total Capital	-	20.78	7.25
Return On Equity %	-	-7.97	-0.74
Return on Common Equity	-	-7.97	-0.74
Margin Analysis
Gross Profit Margin %	82.61	79.9	38.27
SG&A Margin	31.91	38.19	24.02
EBITDA Margin %	37.34	29.18	6.32
EBITA Margin %	37.23	29.12	6.29
EBIT Margin %	37.23	29.12	6.29
Income From Continuing Operations Margin %	-2.31	19.83	0.95
Net Income Margin %	-0.52	15.03	1.1
Net Avail. For Common Margin %	-2.31	19.83	0.95
Normalized Net Income Margin	24.13	19.06	3.79
Levered Free Cash Flow Margin	-	14.56	5.69
Unlevered Free Cash Flow Margin	-	14.56	5.69
Asset Turnover
Asset Turnover	-	0.74	1.35
Fixed Assets Turnover	-	65.63	244.31
Receivables Turnover (Average Receivables)	-	3.54	5.98
Short Term Liquidity
Current Ratio	0.32	0.32	0.31
Quick Ratio	0.22	0.27	0.27
Operating Cash Flow to Current Liabilities	0.03	0	0.04
Days Sales Outstanding (Average Receivables)	-	103.18	61.21
Average Days Payable Outstanding	-	145.69	33.21
Long Term Solvency
Total Debt/Equity	-129.68	-140.91	-143.91
Total Debt / Total Capital	436.95	344.45	327.72
LT Debt/Equity	-0.31	-0.01	-0
Long-Term Debt / Total Capital	1.05	0.02	0
Total Liabilities / Total Assets	302.62	269.57	276.8
Total Debt / EBITDA	10.57	11.46	27.23
Net Debt / EBITDA	8.62	9.27	21.6
Total Debt / (EBITDA - Capex)	10.57	11.47	27.66
Net Debt / (EBITDA - Capex)	8.62	9.29	21.94
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	24.48	92.87
Gross Profit, 1 Yr. Growth %	-	20.39	-7.63
EBITDA, 1 Yr. Growth %	-	-2.72	-58.25
EBITA, 1 Yr. Growth %	-	-2.62	-58.32
EBIT, 1 Yr. Growth %	-	-2.62	-58.32
Earnings From Cont. Operations, 1 Yr. Growth %	-	-1.17K	-90.75
Net Income, 1 Yr. Growth %	-	-3.67K	-85.88
Normalized Net Income, 1 Yr. Growth %	-	-1.7	-61.6
Diluted EPS Before Extra, 1 Yr. Growth %	-	-732.77	-86.09
Accounts Receivable, 1 Yr. Growth %	-	64.25	-16.42
Net Property, Plant and Equip., 1 Yr. Growth %	-	-35.4	-67.99
Total Assets, 1 Yr. Growth %	-	15.37	-2.43
Tangible Book Value, 1 Yr. Growth %	-	-3.41	1.87
Common Equity, 1 Yr. Growth %	-	-3.45	1.71
Cash From Operations, 1 Yr. Growth %	-	-86.3	969.58
Capital Expenditures, 1 Yr. Growth %	-	-	455.25
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-24.57
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-24.57
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	54.95
Gross Profit, 2 Yr. CAGR %	-	-	5.46
EBITDA, 2 Yr. CAGR %	-	-	-36.27
EBITA, 2 Yr. CAGR %	-	-	-36.29
EBIT, 2 Yr. CAGR %	-	-	-36.29
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	-0.6
Net Income, 2 Yr. CAGR %	-	-	124.61
Normalized Net Income, 2 Yr. CAGR %	-	-	-38.57
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-6.19
Accounts Receivable, 2 Yr. CAGR %	-	-	17.16
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	-54.52
Total Assets, 2 Yr. CAGR %	-	-	6.09
Tangible Book Value, 2 Yr. CAGR %	-	-	-0.8
Common Equity, 2 Yr. CAGR %	-	-	-0.9
Cash From Operations, 2 Yr. CAGR %	-	-	21.03